About
Help
My Account
Contact
Map
Subscribe
Home
Home
News
My Practice
Pharmacy Zones
Latest issue
Email bulletin
Advertise
Bookmark this site
Click here to bookmark Pharmacy Europe
Latest News Stories
Valsartan delays progression to type 2 diabetes
Monday 15th March 2010
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT).
Launch of DVD for kidney disease
Friday 12th March 2010
Over 3,000,000 people in the UK are at risk of Chronic Kidney Disease (CKD); 45,000 people in the UK are being treated for kidney failure and the prevalence of kidney failure is increasing at 5% per year.
Merck granted drug trial go-ahead
Friday 12th March 2010
A study into the effects of a heart attack and stroke drug has been given the green-light following a review by an independent safety monitoring board.
Other Stories
Study could improve stroke regimen
Friday 12th March 2010
Dacogen treatment plan approved
Friday 12th March 2010
Bone drug "poses long-term threat"
Thursday 11th March 2010
Deal signed on lung cancer drug
Thursday 11th March 2010
Get RSS news feed
(what's this?)
See all news articles >>
MEDICATION ERRORS
Drug maker recalls swine flu spray
Thursday 24th December 2009
MedImmune recalls almost five million doses of a nasal swine flu vaccine, as the treatment appears to lose strength over time
Patients left in "drug-induced comas"
Tuesday 9th June 2009
Doctor error leaves elderly patients in "drug-induced comas"
See all Medication errors articles >>
CYTOTOXIC HANDLING
GIA announces the release of a comprehensive global report on Lung Cancer...
Wednesday 24th June 2009
Global non-small cell lung cancer therapeutics market to reach $13.3 billion by 2015, according to new report by Global Industry Analysts
Standards for cytotoxic protection: are we asking the right questions? EN374-3...
Monday 6th October 2008
When workers don gloves to handle cytotoxics, can they be sure their glove has the best protection? Should workers have to settle for a mediocre safety standard? Do companies that purchase gloves tested to EN374-3 have employees’ best interests at heart? The answer is simple: No
See all Cytotoxic Handling articles >>
NUTRITION
New colorectal and lung cancer study boost
Thursday 14th May 2009
Patients receiving radiotherapy for lung or colorectal cancer are handed a 67% "boost" from new study
New congress recognises importance of nutrition
Wednesday 13th May 2009
First International Congress of Translational Research in Human Nutrition to be held in Clermont-Ferrand, France
See all Nutrition articles >>
ONCOLOGY
Novartis to develop Incyte drugs
Friday 27th November 2009
Company secures exclusive non-US rights to develop two Incyte JAK inhibitor oral treatments for blood disorders and cancers
Cancer drug approved in North East
Friday 27th November 2009
Cetuximab to be made available on the NHS across the North East as a third line treatment for patients with advanced colorectal tumours
See all Oncology articles >>
LATEST ISSUE
Rheumatoid arthritis; Lipids; biosimilars
INDUSTRY NEWS
NICE rejects new AF drug treatment
Following tests, NICE decided that the benefits of Dronedarone did not outweigh the cost when compared with other treatments
Pfizer anxiety drug rejected by FDA
US Food and Drug Administration rejects a new drug aimed at treating generalised anxiety disorder, it has been revealed
See all Industry News articles >>
MY PRACTICE
RPSGB past president Gill Hawksworth previews the prospectus for the new professional body
PRACTICE
Six allergic reactions to H1N1 jab
Wednesday 25th November 2009
GSK has advised medical staff in Canada to stop using a particular batch of swine-flu vaccine after six recipients became seriously ill
The value of biopharmaceutical innovation to the hospital pharmacist
Monday 13th July 2009
As experts in medicines, there is a role for hospital pharmacists to contribute to economic evaluations demonstrating the value of biopharmaceutical innovation
See all Practice articles >>
ADVERTISEMENT FEATURES
A good time to introduce prefilled syringes
Tuesday 30th September 2008
Prefilled saline intravenous flush syringes are widely used across Europe, yet the UK has been relatively slow to adopt them. This may be about to change with the introduction of prefilled saline syringes by Baxa Ltd
Search the site
All zones
Antibiotics
Barcoding & RFID
Biosimilars
Bone & Joint Disease
Cardiology
Cleanrooms
Clinical Interventions
Clinical Trials
CNS
Coagulation & Thrombolytics
Country
Cytotoxic Handling
Dermatology
Diabetes
Disinfectants
Events
Fungal Infections
Gastroenterology
General
Generics
Haematology
HIV
Hospital Acquired Infection
Industry News
IT & Automation
Medication Errors
Melanomas
Myelodysplastic Syndromes
Nutrition
Oncology
Oncology: Breast
Oncology: Colorectal
Oncology: General
Oncology: Head & Neck
Oncology: Lung
Oncology: Palliative Care
Oncology: Stomach
Pain
Patient Issues
Pharmaceutical Care
Practice
Praxis
Prescribing
Renal Disease
Transplantation
Web design, hosting and programming by ModeZero
